Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Diagnostics Laboratory, |
RCV000760974 | SCV000890878 | pathogenic | Retinitis pigmentosa 3 | 2018-08-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV002464310 | SCV002759662 | pathogenic | not provided | 2019-04-08 | criteria provided, single submitter | clinical testing | |
3billion | RCV000760974 | SCV005904127 | likely pathogenic | Retinitis pigmentosa 3 | 2024-01-09 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Frameshift: predicted to result in a loss or disruption of normal protein function through protein truncation. The predicted truncated protein may be shortened by more than 10%. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000620583 /3billion dataset). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. |